Beta-Lactam Drugs Market, Global Outlook and Forecast 2022-2028

February 2022 | 67 pages | ID: BAB77A9ADD72EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Beta-Lactam Drugs in Global, including the following market information:

Global Beta-Lactam Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Beta-Lactam Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Penicillin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Beta-Lactam Drugs include GlaxoSmithKline plc, Pfizer, Inc., AstraZeneca plc, Merck & Co., Inc., Eli Lilly and Company and Shionogi & Co., Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Beta-Lactam Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Beta-Lactam Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Beta-Lactam Drugs Market Segment Percentages, by Type, 2021 (%)

• Penicillin
• Cephalosporins
• Carbapenem
• Monobacteria

Global Beta-Lactam Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Beta-Lactam Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Beta-Lactam Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Beta-Lactam Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Beta-Lactam Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Beta-Lactam Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline plc
• Pfizer, Inc.
• AstraZeneca plc
• Merck & Co., Inc.
• Eli Lilly and Company
• Shionogi & Co., Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Beta-Lactam Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Beta-Lactam Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BETA-LACTAM DRUGS OVERALL MARKET SIZE

2.1 Global Beta-Lactam Drugs Market Size: 2021 VS 2028
2.2 Global Beta-Lactam Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Beta-Lactam Drugs Players in Global Market
3.2 Top Global Beta-Lactam Drugs Companies Ranked by Revenue
3.3 Global Beta-Lactam Drugs Revenue by Companies
3.4 Top 3 and Top 5 Beta-Lactam Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Beta-Lactam Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Beta-Lactam Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Beta-Lactam Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Beta-Lactam Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Beta-Lactam Drugs Market Size Markets, 2021 & 2028
  4.1.2 Penicillin
  4.1.3 Cephalosporins
  4.1.4 Carbapenem
  4.1.5 Monobacteria
4.2 By Type - Global Beta-Lactam Drugs Revenue & Forecasts
  4.2.1 By Type - Global Beta-Lactam Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Beta-Lactam Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Beta-Lactam Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Beta-Lactam Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Beta-Lactam Drugs Revenue & Forecasts
  5.2.1 By Application - Global Beta-Lactam Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Beta-Lactam Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Beta-Lactam Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Beta-Lactam Drugs Market Size, 2021 & 2028
6.2 By Region - Global Beta-Lactam Drugs Revenue & Forecasts
  6.2.1 By Region - Global Beta-Lactam Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Beta-Lactam Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Beta-Lactam Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Beta-Lactam Drugs Revenue, 2017-2028
  6.3.2 US Beta-Lactam Drugs Market Size, 2017-2028
  6.3.3 Canada Beta-Lactam Drugs Market Size, 2017-2028
  6.3.4 Mexico Beta-Lactam Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Beta-Lactam Drugs Revenue, 2017-2028
  6.4.2 Germany Beta-Lactam Drugs Market Size, 2017-2028
  6.4.3 France Beta-Lactam Drugs Market Size, 2017-2028
  6.4.4 U.K. Beta-Lactam Drugs Market Size, 2017-2028
  6.4.5 Italy Beta-Lactam Drugs Market Size, 2017-2028
  6.4.6 Russia Beta-Lactam Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Beta-Lactam Drugs Market Size, 2017-2028
  6.4.8 Benelux Beta-Lactam Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Beta-Lactam Drugs Revenue, 2017-2028
  6.5.2 China Beta-Lactam Drugs Market Size, 2017-2028
  6.5.3 Japan Beta-Lactam Drugs Market Size, 2017-2028
  6.5.4 South Korea Beta-Lactam Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Beta-Lactam Drugs Market Size, 2017-2028
  6.5.6 India Beta-Lactam Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Beta-Lactam Drugs Revenue, 2017-2028
  6.6.2 Brazil Beta-Lactam Drugs Market Size, 2017-2028
  6.6.3 Argentina Beta-Lactam Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Beta-Lactam Drugs Revenue, 2017-2028
  6.7.2 Turkey Beta-Lactam Drugs Market Size, 2017-2028
  6.7.3 Israel Beta-Lactam Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Beta-Lactam Drugs Market Size, 2017-2028
  6.7.5 UAE Beta-Lactam Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline plc
  7.1.1 GlaxoSmithKline plc Corporate Summary
  7.1.2 GlaxoSmithKline plc Business Overview
  7.1.3 GlaxoSmithKline plc Beta-Lactam Drugs Major Product Offerings
  7.1.4 GlaxoSmithKline plc Beta-Lactam Drugs Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline plc Key News
7.2 Pfizer, Inc.
  7.2.1 Pfizer, Inc. Corporate Summary
  7.2.2 Pfizer, Inc. Business Overview
  7.2.3 Pfizer, Inc. Beta-Lactam Drugs Major Product Offerings
  7.2.4 Pfizer, Inc. Beta-Lactam Drugs Revenue in Global Market (2017-2022)
  7.2.5 Pfizer, Inc. Key News
7.3 AstraZeneca plc
  7.3.1 AstraZeneca plc Corporate Summary
  7.3.2 AstraZeneca plc Business Overview
  7.3.3 AstraZeneca plc Beta-Lactam Drugs Major Product Offerings
  7.3.4 AstraZeneca plc Beta-Lactam Drugs Revenue in Global Market (2017-2022)
  7.3.5 AstraZeneca plc Key News
7.4 Merck & Co., Inc.
  7.4.1 Merck & Co., Inc. Corporate Summary
  7.4.2 Merck & Co., Inc. Business Overview
  7.4.3 Merck & Co., Inc. Beta-Lactam Drugs Major Product Offerings
  7.4.4 Merck & Co., Inc. Beta-Lactam Drugs Revenue in Global Market (2017-2022)
  7.4.5 Merck & Co., Inc. Key News
7.5 Eli Lilly and Company
  7.5.1 Eli Lilly and Company Corporate Summary
  7.5.2 Eli Lilly and Company Business Overview
  7.5.3 Eli Lilly and Company Beta-Lactam Drugs Major Product Offerings
  7.5.4 Eli Lilly and Company Beta-Lactam Drugs Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly and Company Key News
7.6 Shionogi & Co., Ltd.
  7.6.1 Shionogi & Co., Ltd. Corporate Summary
  7.6.2 Shionogi & Co., Ltd. Business Overview
  7.6.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Major Product Offerings
  7.6.4 Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue in Global Market (2017-2022)
  7.6.5 Shionogi & Co., Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Beta-Lactam Drugs Market Opportunities & Trends in Global Market
Table 2. Beta-Lactam Drugs Market Drivers in Global Market
Table 3. Beta-Lactam Drugs Market Restraints in Global Market
Table 4. Key Players of Beta-Lactam Drugs in Global Market
Table 5. Top Beta-Lactam Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Beta-Lactam Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Beta-Lactam Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Beta-Lactam Drugs Product Type
Table 9. List of Global Tier 1 Beta-Lactam Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Beta-Lactam Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Beta-Lactam Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Beta-Lactam Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Beta-Lactam Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Beta-Lactam Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Beta-Lactam Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Beta-Lactam Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Beta-Lactam Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Beta-Lactam Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Beta-Lactam Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Beta-Lactam Drugs Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline plc Corporate Summary
Table 31. GlaxoSmithKline plc Beta-Lactam Drugs Product Offerings
Table 32. GlaxoSmithKline plc Beta-Lactam Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer, Inc. Corporate Summary
Table 34. Pfizer, Inc. Beta-Lactam Drugs Product Offerings
Table 35. Pfizer, Inc. Beta-Lactam Drugs Revenue (US$, Mn), (2017-2022)
Table 36. AstraZeneca plc Corporate Summary
Table 37. AstraZeneca plc Beta-Lactam Drugs Product Offerings
Table 38. AstraZeneca plc Beta-Lactam Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Co., Inc. Corporate Summary
Table 40. Merck & Co., Inc. Beta-Lactam Drugs Product Offerings
Table 41. Merck & Co., Inc. Beta-Lactam Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly and Company Corporate Summary
Table 43. Eli Lilly and Company Beta-Lactam Drugs Product Offerings
Table 44. Eli Lilly and Company Beta-Lactam Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Shionogi & Co., Ltd. Corporate Summary
Table 46. Shionogi & Co., Ltd. Beta-Lactam Drugs Product Offerings
Table 47. Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Beta-Lactam Drugs Segment by Type in 2021
Figure 2. Beta-Lactam Drugs Segment by Application in 2021
Figure 3. Global Beta-Lactam Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Beta-Lactam Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Beta-Lactam Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Beta-Lactam Drugs Revenue in 2021
Figure 8. By Type - Global Beta-Lactam Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Beta-Lactam Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Beta-Lactam Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Beta-Lactam Drugs Revenue Market Share, 2017-2028
Figure 12. US Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Beta-Lactam Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Beta-Lactam Drugs Revenue Market Share, 2017-2028
Figure 24. China Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Beta-Lactam Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Beta-Lactam Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Beta-Lactam Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline plc Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer, Inc. Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AstraZeneca plc Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Co., Inc. Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly and Company Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)